Mary J. Brames

High-Dose Chemotherapy and Stem-Cell Rescue for Metastatic Germ-Cell Tumors

Lawrence H. Einhorn, Stephen D. Williams, Amy R. Chamness et al. · New England Journal of Medicine · 2007 · 487 citations · Full text

Fluoxetine Versus Placebo in Advanced Cancer Outpatients: A Double-Blinded Trial of the Hoosier Oncology Group

Michael Fisch, Patrick J. Loehrer, Jean L. Kristeller et al. · Journal of Clinical Oncology · 2003 · 176 citations

Long-Term Follow-Up of Cisplatin Combination Chemotherapy in Patients With Disseminated Nonseminomatous Germ Cell Tumors: Is a Postchemotherapy Retroperitoneal Lymph Node Dissection Needed After Complete Remission?

Yaron Ehrlich, Mary J. Brames, Stephen D.W. Beck et al. · Journal of Clinical Oncology · 2009 · 169 citations · Full text

Phase II Study of Imatinib Mesylate in Chemotherapy Refractory Germ Cell Tumors Expressing KIT

Lawrence H. Einhorn, Mary J. Brames, Michael C. Heinrich et al. · American Journal of Clinical Oncology · 2006 · 125 citations

Randomized, Double-Blind, Placebo-Controlled, Phase III Cross-Over Study Evaluating the Oral Neurokinin-1 Antagonist Aprepitant in Combination With a 5HT3 Receptor Antagonist and Dexamethasone in Patients With Germ Cell Tumors Receiving 5-Day Cisplatin Combination Chemotherapy Regimens: A Hoosier Oncology Group Study

Costantine Albany, Mary J. Brames, Christopher A. Fausel et al. · Journal of Clinical Oncology · 2012 · 115 citations · Full text